Sign in

CIK 0001775194 · Non-accelerated filer<br>Smaller reporting company

UPEXI, INC.

Sign in to watch
Ticker
UPXI
Exchange
Nasdaq
Industry
Finance Services
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
833378978
Phone
727-287-2800
Business address
3030 N. ROCKY POINT DRIVE, SUITE 420, TAMPA, FL
Former names
GROVE, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-12-16 MARSHALL ALLAN CHIEF EXECUTIVE OFFICER Purchase +4,578 $3.59 $16K 2,575,081
2022-12-15 MARSHALL ALLAN CHIEF EXECUTIVE OFFICER Purchase +2,725 $3.66 $10K 2,570,503
2022-12-14 MARSHALL ALLAN CHIEF EXECUTIVE OFFICER Purchase +10,000 $3.75 $38K 2,567,778
2022-12-09 MARSHALL ALLAN CHIEF EXECUTIVE OFFICER Purchase +12,000 $4.11 $49K 2,557,778
2022-12-01 MARSHALL ALLAN CHIEF EXECUTIVE OFFICER Purchase +18,475 $3.96 $73K 2,545,778
2022-09-30 Salkind Gene Director Grant or award · Stock Option Grant (right to buy) +50,000 50,000
2022-09-30 Williams Thomas Charles Director Grant or award · Stock Option Grant (right to buy) +50,000 50,000
2022-09-30 Dugan Lawrence Director Grant or award · Stock Option Grant (right to buy) +50,000 50,000
2022-03-30 Salkind Gene Director Purchase +125,000 $4.00 $500K 125,000
2021-07-21 Dugan Lawrence Director Grant or award · Option Grant +50,000 50,000
2021-07-21 Williams Thomas Charles Director Grant or award · Option Grant +50,000 50,000
2021-07-21 Salkind Gene Director Grant or award · Option Grant +50,000 50,000
2021-07-21 Norstrud Andrew James CFO Grant or award · Option Grant +200,000 200,000
2021-07-21 MARSHALL ALLAN CEO Grant or award · Option Grant +1,250,000 1,250,000

Page 4 of 4 · 74 trades